Cargando…

The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer

Background: Matrix Metalloproteinases (MMPs) play an indispensable role in the initial alteration and development of PCa. We tried to generate an MMP-related prognostic signature (MMPS) in prostate cancer (PCa). Methods: TCGA-PRAD, MSKCC/GSE21032, GSE116918, GSE70769 cohorts were enrolled to assess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geng, Xinyu, Chen, Chunyang, Huang, Yuhua, Hou, Jianquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359399/ https://www.ncbi.nlm.nih.gov/pubmed/32669958 http://dx.doi.org/10.7150/ijms.46780

Ejemplares similares

Prognostic values of the core components of the mammalian circadian clock in prostate cancer
por: Yue, Wenchang, et al.
Publicado: (2021)

The prognostic values of matrix metalloproteinases in ovarian cancer
por: Zeng, Linchai, et al.
Publicado: (2019)

Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma
por: Mishev, Georgi, et al.
Publicado: (2014)

The prognostic and diagnostic value of tissue inhibitor of metalloproteinases gene family and potential function in gastric cancer
por: Li, Zhao, et al.
Publicado: (2021)

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway
por: Chen, Chunyang, et al.
Publicado: (2021)

Potential Value of Matrix Metalloproteinase-13 as a Biomarker for Osteoarthritis
por: Xin, Xing, et al.
Publicado: (2021)

Study of matrix metalloproteinases and their inhibitors in prostate cancer
por: Escaff, S, et al.
Publicado: (2010)

The prognostic value of histological subtype in patients with metastatic bladder cancer
por: Chen, Cheng, et al.
Publicado: (2017)

Prognostic value of tissue inhibitor of metalloproteinase-matrix metalloproteinase biomarkers at 30 days in patients with acute myocardial infarction without reperfusion therapy
por: Pang, Hui-Fang, et al.
Publicado: (2021)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Prostate health index is useful for prostate cancer detecting in Chinese people
por: Huang, Yuhua, et al.
Publicado: (2019)

Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
por: Wang, Ruo-Xi, et al.
Publicado: (2018)

Evidence for a Proapoptotic Role of Matrix Metalloproteinase-26 in Human Prostate Cancer Cells and Tissues
por: Khamis, Zahraa I., et al.
Publicado: (2016)

Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study
por: Wang, Miaomiao, et al.
Publicado: (2014)

Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
por: Gong, Yixuan, et al.
Publicado: (2014)

Olfactomedin-4 deletion exacerbates DSS-induced colitis through a matrix metalloproteinase-9-dependent mechanism
por: Wang, Xinyu, et al.
Publicado: (2023)

Prognostic Role of Matrix Metalloproteinases in Cervical Cancer: A Meta-Analysis
por: Chen, Weiwei, et al.
Publicado: (2021)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Clusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF-κB-Dependent Mechanism
por: Bonacini, Martina, et al.
Publicado: (2019)

Prognostic role of matrix metalloproteinase 9 in early breast cancer
por: Kalavska, Katarina, et al.
Publicado: (2021)

A Single Nucleotide Polymorphism in HPGD Gene Is Associated with Prostate Cancer Risk
por: Qi, Xiaofei, et al.
Publicado: (2017)

Prognostic role of extracellular matrix metalloproteinase inducer/CD147 in gastrointestinal cancer: a meta-analysis of related studies
por: Huang, Xiaohui, et al.
Publicado: (2016)

Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer
por: Zhang, Yangyu, et al.
Publicado: (2020)

Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?
por: Bonfil, R.D., et al.
Publicado: (2008)

Diagnosis and Prognosis of Prostate Cancer from Circulating Matrix Metalloproteinases and Inhibitors
por: El-Chaer, William Khalil, et al.
Publicado: (2018)

Prognostic value of matrix metalloproteinase-9 expression in oral squamous cell carcinoma and its association with angiogenesis
por: Andisheh-Tadbir, Azadeh, et al.
Publicado: (2016)

Kinetochore-associated protein 1 promotes the invasion and tumorigenicity of cervical cancer cells via matrix metalloproteinase-2 and matrix metalloproteinase-9
por: Wang, Caimei, et al.
Publicado: (2022)

Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer
por: Radisky, Evette S., et al.
Publicado: (2017)

Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey
por: Lin, Yuxin, et al.
Publicado: (2021)

Fatty acid binding protein 4 enhances prostate cancer progression by upregulating matrix metalloproteinases and stromal cell cytokine production
por: Huang, Mingguo, et al.
Publicado: (2017)

Assessment of serum concentrations of matrix metalloproteinase 1, matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases 1 in atopic dermatitis in correlation with disease severity and epidermal barrier parameters
por: Basałygo, Magdalena, et al.
Publicado: (2021)

Mammographic Density and Matrix Metalloproteinases in Breast Tissue
por: Steude, Jana S., et al.
Publicado: (2009)

Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer
por: Kubben, F J G M, et al.
Publicado: (2006)

Pan-cancer analysis of the prognostic and immunological role of matrix metalloproteinase 9
por: Zhang, Jie, et al.
Publicado: (2023)

Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma
por: Štrbac, Danijela, et al.
Publicado: (2017)

Serum Levels of Matrix Metalloproteinase-1 in Brazilian Patients with Benign Prostatic Hyperplasia or Prostate Cancer
por: El-Chaer, William Khalil, et al.
Publicado: (2020)

EGF stimulates glioblastoma metastasis by induction of matrix metalloproteinase-9 in an EGFR-dependent mechanism
por: Chen, Xing-Chen, et al.
Publicado: (2017)

Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer
por: Cheng, Tianyi, et al.
Publicado: (2022)

Prognostic value of interleukin-33, sST2, myeloperoxidase, and matrix metalloproteinase-9 in acute aortic dissection
por: Jia, Yu, et al.
Publicado: (2023)

LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA
por: Chen, Mingwei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_muppof55bk97ggobpu4ql8u9me